Common diabetes drug may 'revolutionize' cancer therapies

Researchers at McGill University and the University of Pennsylvania have discovered that a widely used anti-diabetic drug can boost the immune system and increase the potency of vaccines and cancer treatments. Their findings will be published June 3 in the journal Nature.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news163253883.html">Common diabetes drug may 'revolutionize' cancer therapies</a></p> <p>Researchers at McGill University and the University of Pennsylvania have discovered that a widely used anti-diabetic drug can boost the immune system and increase the potency of vaccines and cancer treatments. Their findings will be published June 3 in the journal <i>Nature</i>.</p>